Catalyst Wire Dossier Catalyst Wire Dossier

Wilate

von Willebrand factor/factor VIII concentrate · Octapharma
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Wilate, covering 2015-03-09 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age [Phase 3]

See pricing